 Leverkusen, Germany, Feb. 26, 2021 GLOBE NEWSWIRE -- Biofrontera AG NASDAQ: BFRA; Frankfurt Stock Exchange: B8F Biofrontera or the Company, an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020. 